The insulin dosage market size value per capita in Greece demonstrated a declining trend from 2013, with a value of $21.42, until 2017. However, starting in 2018, the market began to recover significantly, reaching $26.06 by 2023. The period from 2018 to 2023 shows a strong upward trajectory with notable year-on-year growth: from 2019 to 2020 (+7.24%), 2020 to 2021 (+5.84%), 2021 to 2022 (+4.76%), and 2022 to 2023 (+3.95%). The CAGR over the last five years stands at 5.89%, showcasing a substantial recovery and growth in the insulin market.
Future trends to watch for include potential advancements in diabetes management technology and an aging population, which may further drive market demand. Additionally, monitor policy changes concerning healthcare funding and insulin price regulation, given their potential impact on market dynamics.
